nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—SRC—hematologic cancer	0.131	1	CbGaD
Trabectedin—Alkylating Activity—Busulfan—hematologic cancer	0.0844	0.151	CiPCiCtD
Trabectedin—Alkylating Activity—Lomustine—hematologic cancer	0.0639	0.114	CiPCiCtD
Trabectedin—Alkylating Activity—Procarbazine—hematologic cancer	0.0639	0.114	CiPCiCtD
Trabectedin—Alkylating Activity—Mechlorethamine—hematologic cancer	0.0639	0.114	CiPCiCtD
Trabectedin—Alkylating Activity—Ifosfamide—hematologic cancer	0.0544	0.0973	CiPCiCtD
Trabectedin—Alkylating Activity—Chlorambucil—hematologic cancer	0.0484	0.0867	CiPCiCtD
Trabectedin—Alkylating Activity—Melphalan—hematologic cancer	0.0484	0.0867	CiPCiCtD
Trabectedin—Alkylating Activity—Thiotepa—hematologic cancer	0.0484	0.0867	CiPCiCtD
Trabectedin—Alkylating Activity—Carmustine—hematologic cancer	0.0443	0.0793	CiPCiCtD
Trabectedin—Alkylating Activity—Dacarbazine—hematologic cancer	0.0387	0.0693	CiPCiCtD
Trabectedin—SRC—Dasatinib—hematologic cancer	0.034	0.182	CbGbCtD
Trabectedin—PTGS1—Bortezomib—hematologic cancer	0.00792	0.0423	CbGbCtD
Trabectedin—PTGS1—Thalidomide—hematologic cancer	0.0069	0.0368	CbGbCtD
Trabectedin—PTGS1—Ifosfamide—hematologic cancer	0.00608	0.0324	CbGbCtD
Trabectedin—PTGS1—Imatinib—hematologic cancer	0.0058	0.031	CbGbCtD
Trabectedin—CYP2E1—Thalidomide—hematologic cancer	0.00533	0.0284	CbGbCtD
Trabectedin—CYP2C9—Bexarotene—hematologic cancer	0.0052	0.0278	CbGbCtD
Trabectedin—CYP2E1—Dacarbazine—hematologic cancer	0.00458	0.0245	CbGbCtD
Trabectedin—CYP2D6—Lomustine—hematologic cancer	0.00442	0.0236	CbGbCtD
Trabectedin—CYP2C9—Idarubicin—hematologic cancer	0.00431	0.023	CbGbCtD
Trabectedin—CYP2D6—Idarubicin—hematologic cancer	0.00394	0.021	CbGbCtD
Trabectedin—CYP2C19—Bortezomib—hematologic cancer	0.00384	0.0205	CbGbCtD
Trabectedin—CYP2E1—Mitoxantrone—hematologic cancer	0.00356	0.019	CbGbCtD
Trabectedin—CYP2D6—Hydroxyurea—hematologic cancer	0.00335	0.0179	CbGbCtD
Trabectedin—CYP2C19—Thalidomide—hematologic cancer	0.00334	0.0178	CbGbCtD
Trabectedin—CYP2C9—Bortezomib—hematologic cancer	0.00319	0.017	CbGbCtD
Trabectedin—CYP2C19—Teniposide—hematologic cancer	0.00319	0.017	CbGbCtD
Trabectedin—CYP3A4—Bexarotene—hematologic cancer	0.00303	0.0161	CbGbCtD
Trabectedin—CYP2C19—Ifosfamide—hematologic cancer	0.00294	0.0157	CbGbCtD
Trabectedin—CYP2D6—Bortezomib—hematologic cancer	0.00292	0.0156	CbGbCtD
Trabectedin—PTGS1—Etoposide—hematologic cancer	0.0029	0.0155	CbGbCtD
Trabectedin—CYP3A4—Busulfan—hematologic cancer	0.00281	0.015	CbGbCtD
Trabectedin—CYP3A4—Lomustine—hematologic cancer	0.00281	0.015	CbGbCtD
Trabectedin—CYP2C19—Imatinib—hematologic cancer	0.00281	0.015	CbGbCtD
Trabectedin—CYP2C9—Thalidomide—hematologic cancer	0.00278	0.0148	CbGbCtD
Trabectedin—CYP2C9—Teniposide—hematologic cancer	0.00265	0.0141	CbGbCtD
Trabectedin—CYP3A4—Thiotepa—hematologic cancer	0.00251	0.0134	CbGbCtD
Trabectedin—CYP2C9—Ifosfamide—hematologic cancer	0.00245	0.013	CbGbCtD
Trabectedin—CYP2C9—Imatinib—hematologic cancer	0.00234	0.0125	CbGbCtD
Trabectedin—CYP2E1—Etoposide—hematologic cancer	0.00224	0.012	CbGbCtD
Trabectedin—CYP2D6—Imatinib—hematologic cancer	0.00214	0.0114	CbGbCtD
Trabectedin—CYP2C9—Nilotinib—hematologic cancer	0.00212	0.0113	CbGbCtD
Trabectedin—CYP3A4—Methoxsalen—hematologic cancer	0.00195	0.0104	CbGbCtD
Trabectedin—CYP2D6—Nilotinib—hematologic cancer	0.00194	0.0104	CbGbCtD
Trabectedin—CYP2D6—Vinorelbine—hematologic cancer	0.00193	0.0103	CbGbCtD
Trabectedin—CYP3A4—Bortezomib—hematologic cancer	0.00185	0.00989	CbGbCtD
Trabectedin—CYP2C19—Prednisone—hematologic cancer	0.00185	0.00988	CbGbCtD
Trabectedin—CYP2E1—Dexamethasone—hematologic cancer	0.00184	0.00984	CbGbCtD
Trabectedin—CYP3A4—Daunorubicin—hematologic cancer	0.00177	0.00946	CbGbCtD
Trabectedin—CYP3A4—Cytarabine—hematologic cancer	0.00156	0.00835	CbGbCtD
Trabectedin—CYP3A4—Teniposide—hematologic cancer	0.00154	0.00822	CbGbCtD
Trabectedin—CYP3A4—Ifosfamide—hematologic cancer	0.00142	0.00759	CbGbCtD
Trabectedin—CYP3A4—Imatinib—hematologic cancer	0.00136	0.00725	CbGbCtD
Trabectedin—CYP3A4—Ruxolitinib—hematologic cancer	0.00128	0.00682	CbGbCtD
Trabectedin—CYP3A4—Nilotinib—hematologic cancer	0.00123	0.00659	CbGbCtD
Trabectedin—CYP3A4—Vinorelbine—hematologic cancer	0.00122	0.00653	CbGbCtD
Trabectedin—CYP2C9—Cisplatin—hematologic cancer	0.00119	0.00635	CbGbCtD
Trabectedin—CYP2D6—Vinblastine—hematologic cancer	0.00119	0.00633	CbGbCtD
Trabectedin—CYP2C19—Dexamethasone—hematologic cancer	0.00116	0.00617	CbGbCtD
Trabectedin—CYP3A4—Triamcinolone—hematologic cancer	0.00112	0.00597	CbGbCtD
Trabectedin—CYP3A4—Dasatinib—hematologic cancer	0.00109	0.00582	CbGbCtD
Trabectedin—CYP3A4—Mitoxantrone—hematologic cancer	0.00108	0.00575	CbGbCtD
Trabectedin—CYP2C9—Dexamethasone—hematologic cancer	0.000961	0.00513	CbGbCtD
Trabectedin—CYP3A4—Betamethasone—hematologic cancer	0.000961	0.00512	CbGbCtD
Trabectedin—CYP3A4—Prednisolone—hematologic cancer	0.000948	0.00506	CbGbCtD
Trabectedin—CYP3A4—Prednisone—hematologic cancer	0.000895	0.00477	CbGbCtD
Trabectedin—CYP2D6—Dexamethasone—hematologic cancer	0.000879	0.00469	CbGbCtD
Trabectedin—CYP3A4—Irinotecan—hematologic cancer	0.000848	0.00453	CbGbCtD
Trabectedin—CYP3A4—Vinblastine—hematologic cancer	0.000754	0.00402	CbGbCtD
Trabectedin—CYP3A4—Vincristine—hematologic cancer	0.000742	0.00396	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—hematologic cancer	0.000729	0.00389	CbGbCtD
Trabectedin—CYP3A4—Etoposide—hematologic cancer	0.00068	0.00363	CbGbCtD
Trabectedin—CYP3A4—Dexamethasone—hematologic cancer	0.000559	0.00298	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—hematologic cancer	0.000464	0.00247	CbGbCtD
Trabectedin—SRC—hematopoietic system—hematologic cancer	0.000367	0.111	CbGeAlD
Trabectedin—SRC—gonad—hematologic cancer	0.000279	0.0847	CbGeAlD
Trabectedin—SRC—blood—hematologic cancer	0.000243	0.0738	CbGeAlD
Trabectedin—SRC—lung—hematologic cancer	0.000213	0.0647	CbGeAlD
Trabectedin—SRC—testis—hematologic cancer	0.000201	0.0611	CbGeAlD
Trabectedin—CYP2C19—hematopoietic system—hematologic cancer	0.000194	0.0588	CbGeAlD
Trabectedin—CYP2C9—hematopoietic system—hematologic cancer	0.00015	0.0456	CbGeAlD
Trabectedin—SRC—lymph node—hematologic cancer	0.000146	0.0443	CbGeAlD
Trabectedin—CYP2E1—hematopoietic system—hematologic cancer	0.000142	0.0432	CbGeAlD
Trabectedin—PTGS1—hematopoietic system—hematologic cancer	0.000137	0.0416	CbGeAlD
Trabectedin—CYP2C19—blood—hematologic cancer	0.000128	0.0389	CbGeAlD
Trabectedin—CYP3A4—hematopoietic system—hematologic cancer	0.000114	0.0347	CbGeAlD
Trabectedin—CYP2D6—hematopoietic system—hematologic cancer	0.000113	0.0342	CbGeAlD
Trabectedin—CYP2C9—blood—hematologic cancer	9.94e-05	0.0302	CbGeAlD
Trabectedin—CYP2E1—blood—hematologic cancer	9.42e-05	0.0286	CbGeAlD
Trabectedin—PTGS1—blood—hematologic cancer	9.07e-05	0.0276	CbGeAlD
Trabectedin—CYP2E1—lung—hematologic cancer	8.26e-05	0.0251	CbGeAlD
Trabectedin—PTGS1—lung—hematologic cancer	7.96e-05	0.0242	CbGeAlD
Trabectedin—CYP2E1—testis—hematologic cancer	7.79e-05	0.0237	CbGeAlD
Trabectedin—CYP3A4—blood—hematologic cancer	7.58e-05	0.023	CbGeAlD
Trabectedin—PTGS1—testis—hematologic cancer	7.51e-05	0.0228	CbGeAlD
Trabectedin—CYP2D6—blood—hematologic cancer	7.46e-05	0.0227	CbGeAlD
Trabectedin—CYP2D6—testis—hematologic cancer	6.17e-05	0.0187	CbGeAlD
Trabectedin—PTGS1—lymph node—hematologic cancer	5.44e-05	0.0165	CbGeAlD
Trabectedin—Loss of consciousness—Prednisone—hematologic cancer	1.02e-05	0.000134	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.01e-05	0.000133	CcSEcCtD
Trabectedin—Hypotension—Dexamethasone—hematologic cancer	1.01e-05	0.000133	CcSEcCtD
Trabectedin—Hypotension—Betamethasone—hematologic cancer	1.01e-05	0.000133	CcSEcCtD
Trabectedin—Nausea—Carmustine—hematologic cancer	1.01e-05	0.000133	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—hematologic cancer	1.01e-05	0.000132	CcSEcCtD
Trabectedin—Vomiting—Mitoxantrone—hematologic cancer	1.01e-05	0.000132	CcSEcCtD
Trabectedin—Vomiting—Irinotecan—hematologic cancer	1.01e-05	0.000132	CcSEcCtD
Trabectedin—Nausea—Alitretinoin—hematologic cancer	1e-05	0.000132	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—hematologic cancer	1e-05	0.000132	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—hematologic cancer	9.99e-06	0.000131	CcSEcCtD
Trabectedin—Rash—Mitoxantrone—hematologic cancer	9.98e-06	0.000131	CcSEcCtD
Trabectedin—Rash—Irinotecan—hematologic cancer	9.98e-06	0.000131	CcSEcCtD
Trabectedin—Dermatitis—Irinotecan—hematologic cancer	9.97e-06	0.000131	CcSEcCtD
Trabectedin—Dermatitis—Mitoxantrone—hematologic cancer	9.97e-06	0.000131	CcSEcCtD
Trabectedin—Headache—Mitoxantrone—hematologic cancer	9.92e-06	0.00013	CcSEcCtD
Trabectedin—Headache—Irinotecan—hematologic cancer	9.92e-06	0.00013	CcSEcCtD
Trabectedin—Nausea—Ifosfamide—hematologic cancer	9.9e-06	0.00013	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	9.87e-06	0.00013	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	9.87e-06	0.00013	CcSEcCtD
Trabectedin—Arthralgia—Prednisone—hematologic cancer	9.84e-06	0.000129	CcSEcCtD
Trabectedin—Myalgia—Prednisone—hematologic cancer	9.84e-06	0.000129	CcSEcCtD
Trabectedin—Diarrhoea—Cisplatin—hematologic cancer	9.83e-06	0.000129	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—hematologic cancer	9.81e-06	0.000129	CcSEcCtD
Trabectedin—Vomiting—Gemcitabine—hematologic cancer	9.8e-06	0.000129	CcSEcCtD
Trabectedin—Insomnia—Dexamethasone—hematologic cancer	9.8e-06	0.000129	CcSEcCtD
Trabectedin—Insomnia—Betamethasone—hematologic cancer	9.8e-06	0.000129	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.78e-06	0.000129	CcSEcCtD
Trabectedin—Paraesthesia—Dexamethasone—hematologic cancer	9.73e-06	0.000128	CcSEcCtD
Trabectedin—Paraesthesia—Betamethasone—hematologic cancer	9.73e-06	0.000128	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—hematologic cancer	9.73e-06	0.000128	CcSEcCtD
Trabectedin—Rash—Gemcitabine—hematologic cancer	9.72e-06	0.000128	CcSEcCtD
Trabectedin—Dermatitis—Gemcitabine—hematologic cancer	9.71e-06	0.000128	CcSEcCtD
Trabectedin—Hypersensitivity—Etoposide—hematologic cancer	9.7e-06	0.000128	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—hematologic cancer	9.66e-06	0.000127	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—hematologic cancer	9.66e-06	0.000127	CcSEcCtD
Trabectedin—Headache—Gemcitabine—hematologic cancer	9.66e-06	0.000127	CcSEcCtD
Trabectedin—Nausea—Vincristine—hematologic cancer	9.66e-06	0.000127	CcSEcCtD
Trabectedin—Flushing—Epirubicin—hematologic cancer	9.64e-06	0.000127	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—hematologic cancer	9.61e-06	0.000126	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisolone—hematologic cancer	9.57e-06	0.000126	CcSEcCtD
Trabectedin—Dyspepsia—Betamethasone—hematologic cancer	9.54e-06	0.000125	CcSEcCtD
Trabectedin—Dyspepsia—Dexamethasone—hematologic cancer	9.54e-06	0.000125	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—hematologic cancer	9.47e-06	0.000125	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—hematologic cancer	9.46e-06	0.000124	CcSEcCtD
Trabectedin—Asthenia—Etoposide—hematologic cancer	9.45e-06	0.000124	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—hematologic cancer	9.45e-06	0.000124	CcSEcCtD
Trabectedin—Body temperature increased—Triamcinolone—hematologic cancer	9.44e-06	0.000124	CcSEcCtD
Trabectedin—Oedema—Prednisone—hematologic cancer	9.44e-06	0.000124	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—hematologic cancer	9.43e-06	0.000124	CcSEcCtD
Trabectedin—Decreased appetite—Betamethasone—hematologic cancer	9.42e-06	0.000124	CcSEcCtD
Trabectedin—Decreased appetite—Dexamethasone—hematologic cancer	9.42e-06	0.000124	CcSEcCtD
Trabectedin—Nausea—Irinotecan—hematologic cancer	9.4e-06	0.000124	CcSEcCtD
Trabectedin—Nausea—Mitoxantrone—hematologic cancer	9.4e-06	0.000124	CcSEcCtD
Trabectedin—Infection—Prednisone—hematologic cancer	9.38e-06	0.000123	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—hematologic cancer	9.36e-06	0.000123	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.36e-06	0.000123	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.36e-06	0.000123	CcSEcCtD
Trabectedin—Back pain—Methotrexate—hematologic cancer	9.35e-06	0.000123	CcSEcCtD
Trabectedin—Fatigue—Betamethasone—hematologic cancer	9.34e-06	0.000123	CcSEcCtD
Trabectedin—Fatigue—Dexamethasone—hematologic cancer	9.34e-06	0.000123	CcSEcCtD
Trabectedin—Shock—Prednisone—hematologic cancer	9.29e-06	0.000122	CcSEcCtD
Trabectedin—Nervous system disorder—Prednisone—hematologic cancer	9.26e-06	0.000122	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—hematologic cancer	9.18e-06	0.000121	CcSEcCtD
Trabectedin—Skin disorder—Prednisone—hematologic cancer	9.17e-06	0.000121	CcSEcCtD
Trabectedin—Nausea—Gemcitabine—hematologic cancer	9.16e-06	0.00012	CcSEcCtD
Trabectedin—Vomiting—Cisplatin—hematologic cancer	9.14e-06	0.00012	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—hematologic cancer	9.1e-06	0.00012	CcSEcCtD
Trabectedin—Rash—Cisplatin—hematologic cancer	9.06e-06	0.000119	CcSEcCtD
Trabectedin—Dermatitis—Cisplatin—hematologic cancer	9.05e-06	0.000119	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—hematologic cancer	9.04e-06	0.000119	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—hematologic cancer	9.01e-06	0.000118	CcSEcCtD
Trabectedin—Anorexia—Prednisone—hematologic cancer	9e-06	0.000118	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—hematologic cancer	8.93e-06	0.000117	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—hematologic cancer	8.92e-06	0.000117	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.86e-06	0.000117	CcSEcCtD
Trabectedin—Gastrointestinal pain—Betamethasone—hematologic cancer	8.86e-06	0.000117	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—hematologic cancer	8.86e-06	0.000116	CcSEcCtD
Trabectedin—Hypersensitivity—Triamcinolone—hematologic cancer	8.8e-06	0.000116	CcSEcCtD
Trabectedin—Back pain—Epirubicin—hematologic cancer	8.75e-06	0.000115	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—hematologic cancer	8.72e-06	0.000115	CcSEcCtD
Trabectedin—Dizziness—Etoposide—hematologic cancer	8.71e-06	0.000115	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—hematologic cancer	8.66e-06	0.000114	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—hematologic cancer	8.65e-06	0.000114	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.6e-06	0.000113	CcSEcCtD
Trabectedin—Dizziness—Prednisolone—hematologic cancer	8.59e-06	0.000113	CcSEcCtD
Trabectedin—Asthenia—Triamcinolone—hematologic cancer	8.57e-06	0.000113	CcSEcCtD
Trabectedin—Abdominal pain—Betamethasone—hematologic cancer	8.57e-06	0.000113	CcSEcCtD
Trabectedin—Abdominal pain—Dexamethasone—hematologic cancer	8.57e-06	0.000113	CcSEcCtD
Trabectedin—Body temperature increased—Dexamethasone—hematologic cancer	8.57e-06	0.000113	CcSEcCtD
Trabectedin—Body temperature increased—Betamethasone—hematologic cancer	8.57e-06	0.000113	CcSEcCtD
Trabectedin—Nausea—Cisplatin—hematologic cancer	8.54e-06	0.000112	CcSEcCtD
Trabectedin—Insomnia—Prednisone—hematologic cancer	8.54e-06	0.000112	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—hematologic cancer	8.49e-06	0.000112	CcSEcCtD
Trabectedin—Paraesthesia—Prednisone—hematologic cancer	8.47e-06	0.000111	CcSEcCtD
Trabectedin—Cough—Methotrexate—hematologic cancer	8.43e-06	0.000111	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—hematologic cancer	8.42e-06	0.000111	CcSEcCtD
Trabectedin—Vomiting—Etoposide—hematologic cancer	8.37e-06	0.00011	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—hematologic cancer	8.37e-06	0.00011	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—hematologic cancer	8.36e-06	0.00011	CcSEcCtD
Trabectedin—Dyspepsia—Prednisone—hematologic cancer	8.31e-06	0.000109	CcSEcCtD
Trabectedin—Rash—Etoposide—hematologic cancer	8.3e-06	0.000109	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—hematologic cancer	8.29e-06	0.000109	CcSEcCtD
Trabectedin—Headache—Etoposide—hematologic cancer	8.25e-06	0.000108	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—hematologic cancer	8.23e-06	0.000108	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—hematologic cancer	8.23e-06	0.000108	CcSEcCtD
Trabectedin—Decreased appetite—Prednisone—hematologic cancer	8.2e-06	0.000108	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—hematologic cancer	8.19e-06	0.000108	CcSEcCtD
Trabectedin—Rash—Prednisolone—hematologic cancer	8.19e-06	0.000108	CcSEcCtD
Trabectedin—Dermatitis—Prednisolone—hematologic cancer	8.18e-06	0.000108	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.17e-06	0.000107	CcSEcCtD
Trabectedin—Fatigue—Prednisone—hematologic cancer	8.14e-06	0.000107	CcSEcCtD
Trabectedin—Headache—Prednisolone—hematologic cancer	8.14e-06	0.000107	CcSEcCtD
Trabectedin—Syncope—Epirubicin—hematologic cancer	8.11e-06	0.000107	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—hematologic cancer	8.1e-06	0.000106	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—hematologic cancer	8.09e-06	0.000106	CcSEcCtD
Trabectedin—Constipation—Prednisone—hematologic cancer	8.07e-06	0.000106	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—hematologic cancer	7.95e-06	0.000105	CcSEcCtD
Trabectedin—Dizziness—Triamcinolone—hematologic cancer	7.9e-06	0.000104	CcSEcCtD
Trabectedin—Cough—Epirubicin—hematologic cancer	7.89e-06	0.000104	CcSEcCtD
Trabectedin—Infection—Methotrexate—hematologic cancer	7.84e-06	0.000103	CcSEcCtD
Trabectedin—Nausea—Etoposide—hematologic cancer	7.82e-06	0.000103	CcSEcCtD
Trabectedin—Asthenia—Betamethasone—hematologic cancer	7.78e-06	0.000102	CcSEcCtD
Trabectedin—Asthenia—Dexamethasone—hematologic cancer	7.78e-06	0.000102	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—hematologic cancer	7.73e-06	0.000102	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—hematologic cancer	7.73e-06	0.000102	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—hematologic cancer	7.72e-06	0.000102	CcSEcCtD
Trabectedin—Gastrointestinal pain—Prednisone—hematologic cancer	7.72e-06	0.000101	CcSEcCtD
Trabectedin—Nausea—Prednisolone—hematologic cancer	7.71e-06	0.000101	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—hematologic cancer	7.7e-06	0.000101	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—hematologic cancer	7.7e-06	0.000101	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—hematologic cancer	7.66e-06	0.000101	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.65e-06	0.000101	CcSEcCtD
Trabectedin—Vomiting—Triamcinolone—hematologic cancer	7.59e-06	9.99e-05	CcSEcCtD
Trabectedin—Rash—Triamcinolone—hematologic cancer	7.53e-06	9.9e-05	CcSEcCtD
Trabectedin—Dermatitis—Triamcinolone—hematologic cancer	7.52e-06	9.89e-05	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—hematologic cancer	7.52e-06	9.89e-05	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—hematologic cancer	7.5e-06	9.87e-05	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—hematologic cancer	7.49e-06	9.85e-05	CcSEcCtD
Trabectedin—Headache—Triamcinolone—hematologic cancer	7.48e-06	9.84e-05	CcSEcCtD
Trabectedin—Abdominal pain—Prednisone—hematologic cancer	7.46e-06	9.81e-05	CcSEcCtD
Trabectedin—Body temperature increased—Prednisone—hematologic cancer	7.46e-06	9.81e-05	CcSEcCtD
Trabectedin—Diarrhoea—Dexamethasone—hematologic cancer	7.41e-06	9.75e-05	CcSEcCtD
Trabectedin—Diarrhoea—Betamethasone—hematologic cancer	7.41e-06	9.75e-05	CcSEcCtD
Trabectedin—Oedema—Epirubicin—hematologic cancer	7.38e-06	9.71e-05	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—hematologic cancer	7.37e-06	9.69e-05	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—hematologic cancer	7.36e-06	9.67e-05	CcSEcCtD
Trabectedin—Infection—Epirubicin—hematologic cancer	7.33e-06	9.64e-05	CcSEcCtD
Trabectedin—Cough—Doxorubicin—hematologic cancer	7.3e-06	9.6e-05	CcSEcCtD
Trabectedin—Shock—Epirubicin—hematologic cancer	7.26e-06	9.55e-05	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—hematologic cancer	7.24e-06	9.52e-05	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—hematologic cancer	7.23e-06	9.5e-05	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.19e-06	9.45e-05	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—hematologic cancer	7.17e-06	9.43e-05	CcSEcCtD
Trabectedin—Dizziness—Betamethasone—hematologic cancer	7.17e-06	9.42e-05	CcSEcCtD
Trabectedin—Dizziness—Dexamethasone—hematologic cancer	7.17e-06	9.42e-05	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—hematologic cancer	7.13e-06	9.38e-05	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—hematologic cancer	7.12e-06	9.37e-05	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—hematologic cancer	7.12e-06	9.37e-05	CcSEcCtD
Trabectedin—Nausea—Triamcinolone—hematologic cancer	7.09e-06	9.33e-05	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—hematologic cancer	7.08e-06	9.31e-05	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.08e-06	9.3e-05	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—hematologic cancer	7.04e-06	9.25e-05	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—hematologic cancer	7.03e-06	9.25e-05	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisone—hematologic cancer	6.95e-06	9.14e-05	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—hematologic cancer	6.94e-06	9.13e-05	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—hematologic cancer	6.9e-06	9.07e-05	CcSEcCtD
Trabectedin—Vomiting—Betamethasone—hematologic cancer	6.89e-06	9.06e-05	CcSEcCtD
Trabectedin—Vomiting—Dexamethasone—hematologic cancer	6.89e-06	9.06e-05	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—hematologic cancer	6.86e-06	9.02e-05	CcSEcCtD
Trabectedin—Rash—Dexamethasone—hematologic cancer	6.83e-06	8.99e-05	CcSEcCtD
Trabectedin—Rash—Betamethasone—hematologic cancer	6.83e-06	8.99e-05	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—hematologic cancer	6.83e-06	8.98e-05	CcSEcCtD
Trabectedin—Dermatitis—Dexamethasone—hematologic cancer	6.83e-06	8.98e-05	CcSEcCtD
Trabectedin—Dermatitis—Betamethasone—hematologic cancer	6.83e-06	8.98e-05	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.81e-06	8.95e-05	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—hematologic cancer	6.8e-06	8.94e-05	CcSEcCtD
Trabectedin—Headache—Betamethasone—hematologic cancer	6.79e-06	8.93e-05	CcSEcCtD
Trabectedin—Headache—Dexamethasone—hematologic cancer	6.79e-06	8.93e-05	CcSEcCtD
Trabectedin—Infection—Doxorubicin—hematologic cancer	6.78e-06	8.92e-05	CcSEcCtD
Trabectedin—Asthenia—Prednisone—hematologic cancer	6.77e-06	8.9e-05	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.72e-06	8.84e-05	CcSEcCtD
Trabectedin—Shock—Doxorubicin—hematologic cancer	6.72e-06	8.84e-05	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—hematologic cancer	6.7e-06	8.81e-05	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—hematologic cancer	6.69e-06	8.79e-05	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—hematologic cancer	6.68e-06	8.78e-05	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—hematologic cancer	6.63e-06	8.72e-05	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—hematologic cancer	6.63e-06	8.72e-05	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—hematologic cancer	6.58e-06	8.65e-05	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—hematologic cancer	6.51e-06	8.56e-05	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—hematologic cancer	6.5e-06	8.54e-05	CcSEcCtD
Trabectedin—Diarrhoea—Prednisone—hematologic cancer	6.46e-06	8.49e-05	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—hematologic cancer	6.45e-06	8.48e-05	CcSEcCtD
Trabectedin—Nausea—Dexamethasone—hematologic cancer	6.44e-06	8.46e-05	CcSEcCtD
Trabectedin—Nausea—Betamethasone—hematologic cancer	6.44e-06	8.46e-05	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—hematologic cancer	6.42e-06	8.44e-05	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—hematologic cancer	6.38e-06	8.39e-05	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.37e-06	8.38e-05	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—hematologic cancer	6.36e-06	8.37e-05	CcSEcCtD
Trabectedin—Constipation—Epirubicin—hematologic cancer	6.31e-06	8.3e-05	CcSEcCtD
Trabectedin—Dizziness—Prednisone—hematologic cancer	6.24e-06	8.21e-05	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—hematologic cancer	6.24e-06	8.2e-05	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—hematologic cancer	6.24e-06	8.2e-05	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.22e-06	8.18e-05	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—hematologic cancer	6.18e-06	8.12e-05	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—hematologic cancer	6.13e-06	8.06e-05	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—hematologic cancer	6.09e-06	8.01e-05	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—hematologic cancer	6.04e-06	7.94e-05	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—hematologic cancer	6.01e-06	7.91e-05	CcSEcCtD
Trabectedin—Vomiting—Prednisone—hematologic cancer	6e-06	7.89e-05	CcSEcCtD
Trabectedin—Rash—Prednisone—hematologic cancer	5.95e-06	7.82e-05	CcSEcCtD
Trabectedin—Dermatitis—Prednisone—hematologic cancer	5.95e-06	7.82e-05	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—hematologic cancer	5.94e-06	7.81e-05	CcSEcCtD
Trabectedin—Headache—Prednisone—hematologic cancer	5.91e-06	7.77e-05	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.9e-06	7.75e-05	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—hematologic cancer	5.89e-06	7.74e-05	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—hematologic cancer	5.84e-06	7.68e-05	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—hematologic cancer	5.83e-06	7.67e-05	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—hematologic cancer	5.83e-06	7.67e-05	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—hematologic cancer	5.81e-06	7.64e-05	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—hematologic cancer	5.66e-06	7.44e-05	CcSEcCtD
Trabectedin—Nausea—Prednisone—hematologic cancer	5.61e-06	7.37e-05	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.58e-06	7.34e-05	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—hematologic cancer	5.44e-06	7.15e-05	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—hematologic cancer	5.4e-06	7.1e-05	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—hematologic cancer	5.4e-06	7.1e-05	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—hematologic cancer	5.4e-06	7.1e-05	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—hematologic cancer	5.3e-06	6.96e-05	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—hematologic cancer	5.22e-06	6.86e-05	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—hematologic cancer	5.05e-06	6.64e-05	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—hematologic cancer	5.03e-06	6.62e-05	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—hematologic cancer	5.01e-06	6.59e-05	CcSEcCtD
Trabectedin—Rash—Methotrexate—hematologic cancer	4.97e-06	6.54e-05	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—hematologic cancer	4.97e-06	6.53e-05	CcSEcCtD
Trabectedin—Headache—Methotrexate—hematologic cancer	4.94e-06	6.5e-05	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—hematologic cancer	4.9e-06	6.44e-05	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—hematologic cancer	4.88e-06	6.42e-05	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—hematologic cancer	4.69e-06	6.17e-05	CcSEcCtD
Trabectedin—Nausea—Methotrexate—hematologic cancer	4.68e-06	6.16e-05	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—hematologic cancer	4.67e-06	6.14e-05	CcSEcCtD
Trabectedin—Rash—Epirubicin—hematologic cancer	4.65e-06	6.12e-05	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—hematologic cancer	4.65e-06	6.11e-05	CcSEcCtD
Trabectedin—Headache—Epirubicin—hematologic cancer	4.62e-06	6.08e-05	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—hematologic cancer	4.52e-06	5.94e-05	CcSEcCtD
Trabectedin—Nausea—Epirubicin—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—hematologic cancer	4.34e-06	5.71e-05	CcSEcCtD
Trabectedin—Rash—Doxorubicin—hematologic cancer	4.31e-06	5.66e-05	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—hematologic cancer	4.3e-06	5.66e-05	CcSEcCtD
Trabectedin—Headache—Doxorubicin—hematologic cancer	4.28e-06	5.63e-05	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—hematologic cancer	4.06e-06	5.33e-05	CcSEcCtD
Trabectedin—SRC—Disease—CREBBP—hematologic cancer	1.25e-06	2.87e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.24e-06	2.86e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.24e-06	2.85e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FOXO1—hematologic cancer	1.24e-06	2.85e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDGFRB—hematologic cancer	1.23e-06	2.84e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.23e-06	2.83e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—hematologic cancer	1.23e-06	2.83e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGF2—hematologic cancer	1.23e-06	2.82e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—hematologic cancer	1.22e-06	2.82e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—hematologic cancer	1.22e-06	2.81e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDGFRA—hematologic cancer	1.22e-06	2.8e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.21e-06	2.79e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JAK1—hematologic cancer	1.21e-06	2.79e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PRKCG—hematologic cancer	1.21e-06	2.79e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3R1—hematologic cancer	1.21e-06	2.79e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CA9—hematologic cancer	1.21e-06	2.77e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ACP5—hematologic cancer	1.21e-06	2.77e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—hematologic cancer	1.2e-06	2.77e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NQO1—hematologic cancer	1.2e-06	2.76e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CD44—hematologic cancer	1.2e-06	2.76e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTM1—hematologic cancer	1.19e-06	2.75e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NCOR1—hematologic cancer	1.19e-06	2.75e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAP2K1—hematologic cancer	1.19e-06	2.74e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.19e-06	2.74e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.19e-06	2.73e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CD—hematologic cancer	1.18e-06	2.72e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—JAK2—hematologic cancer	1.18e-06	2.71e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.18e-06	2.71e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—hematologic cancer	1.17e-06	2.7e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—hematologic cancer	1.17e-06	2.69e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2—hematologic cancer	1.17e-06	2.68e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.16e-06	2.67e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNG—hematologic cancer	1.15e-06	2.66e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MDM2—hematologic cancer	1.15e-06	2.64e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYCS—hematologic cancer	1.14e-06	2.61e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—IDH1—hematologic cancer	1.13e-06	2.61e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—FGF2—hematologic cancer	1.13e-06	2.61e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2RA—hematologic cancer	1.13e-06	2.6e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.13e-06	2.6e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—hematologic cancer	1.12e-06	2.58e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.12e-06	2.58e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.12e-06	2.58e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TXN—hematologic cancer	1.12e-06	2.58e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—hematologic cancer	1.12e-06	2.57e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3R1—hematologic cancer	1.12e-06	2.57e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MTOR—hematologic cancer	1.12e-06	2.57e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CB—hematologic cancer	1.12e-06	2.57e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD4—hematologic cancer	1.12e-06	2.57e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NQO1—hematologic cancer	1.1e-06	2.54e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CD44—hematologic cancer	1.1e-06	2.54e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CREBBP—hematologic cancer	1.1e-06	2.53e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.1e-06	2.52e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NQO1—hematologic cancer	1.09e-06	2.52e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CD44—hematologic cancer	1.09e-06	2.52e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDGFB—hematologic cancer	1.09e-06	2.51e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—JAK2—hematologic cancer	1.09e-06	2.5e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—hematologic cancer	1.08e-06	2.49e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—hematologic cancer	1.08e-06	2.49e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.07e-06	2.47e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSC2—hematologic cancer	1.07e-06	2.46e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—hematologic cancer	1.06e-06	2.44e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MDM2—hematologic cancer	1.06e-06	2.44e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MTHFR—hematologic cancer	1.05e-06	2.43e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.05e-06	2.42e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—hematologic cancer	1.05e-06	2.41e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYCS—hematologic cancer	1.04e-06	2.41e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.04e-06	2.4e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—hematologic cancer	1.04e-06	2.39e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.04e-06	2.39e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYCS—hematologic cancer	1.04e-06	2.38e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—hematologic cancer	1.04e-06	2.38e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MTOR—hematologic cancer	1.03e-06	2.37e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CB—hematologic cancer	1.03e-06	2.37e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL1B—hematologic cancer	1.03e-06	2.37e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CD4—hematologic cancer	1.03e-06	2.37e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.03e-06	2.37e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—hematologic cancer	1.03e-06	2.37e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGFR3—hematologic cancer	1.03e-06	2.36e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—hematologic cancer	1.03e-06	2.36e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.02e-06	2.36e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.02e-06	2.36e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK14—hematologic cancer	1.02e-06	2.34e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.02e-06	2.34e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTP1—hematologic cancer	1e-06	2.3e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.99e-07	2.3e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—JUN—hematologic cancer	9.98e-07	2.3e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ESR1—hematologic cancer	9.97e-07	2.3e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FN1—hematologic cancer	9.85e-07	2.27e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3R1—hematologic cancer	9.84e-07	2.26e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NFKBIA—hematologic cancer	9.73e-07	2.24e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BAD—hematologic cancer	9.73e-07	2.24e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.69e-07	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—hematologic cancer	9.68e-07	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—hematologic cancer	9.68e-07	2.23e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NUP98—hematologic cancer	9.67e-07	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—hematologic cancer	9.65e-07	2.22e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—hematologic cancer	9.64e-07	2.22e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—hematologic cancer	9.55e-07	2.2e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—hematologic cancer	9.48e-07	2.18e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK8—hematologic cancer	9.44e-07	2.17e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD80—hematologic cancer	9.44e-07	2.17e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KIT—hematologic cancer	9.43e-07	2.17e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CG—hematologic cancer	9.43e-07	2.17e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ADCY7—hematologic cancer	9.39e-07	2.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA3—hematologic cancer	9.39e-07	2.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NUP214—hematologic cancer	9.32e-07	2.15e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.26e-07	2.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTPN11—hematologic cancer	9.26e-07	2.13e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTP1—hematologic cancer	9.21e-07	2.12e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—hematologic cancer	9.21e-07	2.12e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTM1—hematologic cancer	9.2e-07	2.12e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NCOR1—hematologic cancer	9.2e-07	2.12e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—hematologic cancer	9.17e-07	2.11e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTR—hematologic cancer	9.13e-07	2.1e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCG2—hematologic cancer	9.13e-07	2.1e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTP1—hematologic cancer	9.13e-07	2.1e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CB—hematologic cancer	9.08e-07	2.09e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CREB1—hematologic cancer	8.97e-07	2.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ENO2—hematologic cancer	8.96e-07	2.06e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—hematologic cancer	8.93e-07	2.06e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—hematologic cancer	8.91e-07	2.05e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BRAF—hematologic cancer	8.86e-07	2.04e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CG—hematologic cancer	8.86e-07	2.04e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.83e-07	2.03e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL2—hematologic cancer	8.78e-07	2.02e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6R—hematologic cancer	8.75e-07	2.01e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CREBBP—hematologic cancer	8.74e-07	2.01e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—hematologic cancer	8.72e-07	2.01e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTT1—hematologic cancer	8.69e-07	2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—hematologic cancer	8.64e-07	1.99e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—hematologic cancer	8.63e-07	1.99e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—hematologic cancer	8.61e-07	1.98e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—hematologic cancer	8.5e-07	1.96e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SDC1—hematologic cancer	8.49e-07	1.95e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTM1—hematologic cancer	8.46e-07	1.95e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NCOR1—hematologic cancer	8.46e-07	1.95e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTM1—hematologic cancer	8.39e-07	1.93e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NCOR1—hematologic cancer	8.39e-07	1.93e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAP2K1—hematologic cancer	8.34e-07	1.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CD—hematologic cancer	8.29e-07	1.91e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK3—hematologic cancer	8.25e-07	1.9e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CREBBP—hematologic cancer	8.21e-07	1.89e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MTHFR—hematologic cancer	8.13e-07	1.87e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—hematologic cancer	7.97e-07	1.83e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—hematologic cancer	7.95e-07	1.83e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGF2—hematologic cancer	7.93e-07	1.83e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—hematologic cancer	7.85e-07	1.81e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3R1—hematologic cancer	7.83e-07	1.8e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CD—hematologic cancer	7.79e-07	1.79e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—hematologic cancer	7.69e-07	1.77e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK3—hematologic cancer	7.62e-07	1.75e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JAK2—hematologic cancer	7.61e-07	1.75e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—hematologic cancer	7.48e-07	1.72e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MTHFR—hematologic cancer	7.48e-07	1.72e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MDM2—hematologic cancer	7.42e-07	1.71e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MTHFR—hematologic cancer	7.42e-07	1.71e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—hematologic cancer	7.41e-07	1.71e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—hematologic cancer	7.41e-07	1.7e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—hematologic cancer	7.39e-07	1.7e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3R1—hematologic cancer	7.35e-07	1.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CB—hematologic cancer	7.22e-07	1.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MTOR—hematologic cancer	7.22e-07	1.66e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CD44—hematologic cancer	7.22e-07	1.66e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NQO1—hematologic cancer	7.22e-07	1.66e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.17e-07	1.65e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—hematologic cancer	6.84e-07	1.58e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	6.83e-07	1.57e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYCS—hematologic cancer	6.83e-07	1.57e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—hematologic cancer	6.81e-07	1.57e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.79e-07	1.56e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CB—hematologic cancer	6.79e-07	1.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—hematologic cancer	6.78e-07	1.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—hematologic cancer	6.64e-07	1.53e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—hematologic cancer	6.63e-07	1.53e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.54e-07	1.5e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—hematologic cancer	6.47e-07	1.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JUN—hematologic cancer	6.45e-07	1.49e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CREBBP—hematologic cancer	6.34e-07	1.46e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—hematologic cancer	6.3e-07	1.45e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—hematologic cancer	6.29e-07	1.45e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	6.29e-07	1.45e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—hematologic cancer	6.26e-07	1.44e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—hematologic cancer	6.24e-07	1.44e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	6.23e-07	1.43e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK8—hematologic cancer	6.11e-07	1.41e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—hematologic cancer	6.03e-07	1.39e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.02e-07	1.39e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	6.01e-07	1.38e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—hematologic cancer	5.95e-07	1.37e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—hematologic cancer	5.93e-07	1.36e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—hematologic cancer	5.86e-07	1.35e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.83e-07	1.34e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—hematologic cancer	5.82e-07	1.34e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.78e-07	1.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.7e-07	1.31e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	5.67e-07	1.31e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—hematologic cancer	5.64e-07	1.3e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—hematologic cancer	5.59e-07	1.29e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—hematologic cancer	5.58e-07	1.28e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—hematologic cancer	5.57e-07	1.28e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—hematologic cancer	5.57e-07	1.28e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—hematologic cancer	5.56e-07	1.28e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—hematologic cancer	5.54e-07	1.27e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.53e-07	1.27e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.53e-07	1.27e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.53e-07	1.27e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	5.48e-07	1.26e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—hematologic cancer	5.45e-07	1.26e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—hematologic cancer	5.41e-07	1.24e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK3—hematologic cancer	5.33e-07	1.23e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	5.24e-07	1.21e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	5.22e-07	1.2e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—hematologic cancer	5.19e-07	1.19e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—hematologic cancer	5.17e-07	1.19e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	5.17e-07	1.19e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—hematologic cancer	5.14e-07	1.18e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.89e-07	1.13e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.82e-07	1.11e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—hematologic cancer	4.79e-07	1.1e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.77e-07	1.1e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—hematologic cancer	4.52e-07	1.04e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—hematologic cancer	4.52e-07	1.04e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—hematologic cancer	4.4e-07	1.01e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—hematologic cancer	4.31e-07	9.93e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—hematologic cancer	4.26e-07	9.8e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—hematologic cancer	4.16e-07	9.58e-06	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—hematologic cancer	4.14e-07	9.52e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—hematologic cancer	4.13e-07	9.49e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.11e-07	9.46e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—hematologic cancer	4.07e-07	9.38e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—hematologic cancer	3.97e-07	9.13e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—hematologic cancer	3.93e-07	9.05e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—hematologic cancer	3.9e-07	8.97e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.81e-07	8.77e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.61e-07	8.31e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—hematologic cancer	3.6e-07	8.28e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—hematologic cancer	3.57e-07	8.21e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.41e-07	7.85e-06	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—hematologic cancer	3.38e-07	7.78e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	3.19e-07	7.35e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.15e-07	7.25e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.94e-07	6.76e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.91e-07	6.7e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—hematologic cancer	2.72e-07	6.26e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—hematologic cancer	2.61e-07	6e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—hematologic cancer	2.59e-07	5.97e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—hematologic cancer	2.4e-07	5.52e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—hematologic cancer	2.38e-07	5.47e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.92e-07	4.42e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—hematologic cancer	1.57e-07	3.61e-06	CbGpPWpGaD
